Loading organizations...
Loading organizations...
Developing LXR-based therapies for inflammatory skin disorders.
Ralexar Therapeutics has raised $21.5M across 1 funding round.
Ralexar Therapeutics has raised $21.5M in total across 1 funding round.
Ralexar Therapeutics has raised $21.5M in total across 1 funding round.
Ralexar Therapeutics's investors include Jason Hong, Palo Alto Investors.
Ralexar Therapeutics has raised $21.5M across 1 funding round. Most recently, it raised $21.5M Series A in January 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 2, 2014 | $21.5M Series A | Jason Hong | Palo Alto Investors |